GreenVision Acquisition Corp.
GRNVR
NASDAQ Global Select1.34
USD
+0.65
- -
CIK
0001788841
ISIN
US39678G1296
CUSIP
39678G129
Return %
Stock
S&P500
1Y
- -
26.53
3Y
- -
76.60
5Y
644.44
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- None
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- DE United States of America
- IPO Date
- Dec 9, 2019
- CIK
- 0001788841
- Similar Companies
- Business
- GreenVision Acquisition Corp. (GRNVR) operates as a blank check company, or special purpose acquisition company (SPAC), formed to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more target businesses, primarily targeting opportunities in the life sciences and healthcare industries across North America, Europe, and Asia (excluding China); it offers no current products or services beyond its SPAC structure, including units comprising common stock, redeemable warrants exercisable at $11.50 per share, and rights to one-tenth of a share of common stock. Incorporated in 2019 under Delaware law and headquartered in Dover, Delaware, the company raised $57.5 million in its November 2019 initial public offering, depositing proceeds into a trust account for deployment in an initial business combination. GreenVision entered into a definitive merger agreement with Accountable Healthcare America, Inc., a population health management company, in August 2020, which was subsequently terminated; it then announced a business combination with Helbiz, Inc., a micro-mobility provider, in February 2021, which closed in August 2021, resulting in GreenVision operating as a subsidiary of Helbiz, Inc., with its rights delisted from Nasdaq and trading over-the-counter at minimal volume as of late 2025. No further acquisitions, partnerships, funding rounds, product launches, or operational expansions have occurred since the Helbiz transaction, leaving GRNVR as a residual SPAC security with weak financial metrics including zero profit margin and negative ROE.